A half dozen medical stocks joined a gold miner and an aerospace/defense company earning spots on various IBD stock lists Tuesday. Several joined more than one list. Halozyme Therapeutics (), which is pioneering new cancer treatments, rose onto Sector Leaders and the Stock Spotlight. Top-rated gold miner Franco-Nevada () landed in the Big Cap 20 and Stock Spotlight. Meanwhile, aerospace/defense firm Karman () (), which designs systems for missile, defense and space programs, joined the IPO Leaders and Stock Spotlight. Other medical stocks that made it onto IBD best stock lists with Halozyme include BeOne Medicines (), TransMedics (), Tarsus Pharma (), Medpace () and Hinge Health (). In all, 14 stocks made it onto IBD best stock watchlists. IBD best stock screens are regularly updated to add new stocks, as well as weed out those that have started to show weakness. In the tables below, you'll see which stocks have been added to or removed from lists like the IBD 50, Sector Leaders and the IBD Big Cap 20. \n\nMedical Pioneer Halozyme Reports Huge Profit Gains Halozyme is at the cutting edge of medicine. It develops recombinant human enzymes and novel oncology medicines that target tumors. Medical standout Halozyme boasts a best-possible 99. Last quarter it reported a 69% surge in earnings to $1.54 per share on 41% higher revenue of $325.7 million. The prior three quarters its EPS rose 69%, 54% and 41%. Check this column each day to help build and maintain your list of stocks to watch with alerts to the most recent changes. But never buy a stock just because it's on an IBD list. Be sure to do your own research and run all your stock ideas through a due diligence process. And you can use IBD's tools to quickly track general market trends, find stocks to watch, and pinpoint the best time to buy and sell. Changes made as of Aug. 12, 2025 5:50 p.m. ET.\n\nIBD 50 Four medical stocks came aboard IBD's flagship screen of the best growth stocks to watch. The IBD 50 gives you 50 companies showing strong relative price strength and top-notch fundamentals. Before you decide what stocks to buy, always check out these new and innovative stocks that historically far outperform the S&P 500.\n\nIBD Sector Leaders: Lone Medical Stock Qualifies IBD's most stringent and powerful screen, Sector Leaders highlights the best growth stocks in IBD's 33 sectors. Just one stock, Halozyme Therapeutics, made the grade Tuesday. All IBD Sector Leaders show outstanding earnings and sales growth in recent quarters and are strong across many other fundamental and price-performance metrics.\n\nIBD Big Cap 20 Franco-Nevada is accompanied into the Big Cap 20 by Credo Tech (), whose components are helping companies develop artificial intelligence products. This daily screen uncovers top-rated, large-cap growth stocks for your consideration. Big Cap 20 companies can deliver outsize gains without the volatility of smaller growth stocks.\n\nIPO Leaders Recent IPO stocks are where you often find some of the market's best stocks. New IPOs are typically in their early stages of growth, and it's big earnings growth that generally fuels a stock's price performance. IPO Leaders has special screening criteria to find up-and-coming stocks with strong fundamental and technical traits.\n\nStock Spotlight Halozyme is joined in the Spotlight by BeOne Medicines, a leader in cancer treatments. This daily stock list seeks out the best stocks to buy and watch with top fundamentals that are getting ready to break out. Use it to glean emerging industry and sector trends in the market.

Medical, Gold, Aerospace Stocks Join Best Stocks Lists: Check Out IBD 50, The Big Cap 20, Stock Spotlight And Others

Several medical, gold mining, and aerospace companies earned spots on various IBD best stock lists as of August 12, 2025. Halozyme Therapeutics, a medical company developing cancer treatments, was included in the Sector Leaders and Stock Spotlight lists. Franco-Nevada, a top-rated gold miner, joined the Big Cap 20 and Stock Spotlight. Karman, an aerospace and defense firm, made the IPO Leaders and Stock Spotlight lists. Other medical companies such as BeOne Medicines, TransMedics, Tarsus Pharma, Medpace, and Hinge Health also joined IBD best stock watchlists. The IBD best stock screens are updated regularly to reflect strong performance and fundamentals, with changes effective as of August 12, 2025.